Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2020.
The company has reported 19.97% rise in its net profit of Rs 277.35 crore for the quarter under review as against net profit of Rs 231.19 crore for the same quarter in the previous year. Total income of the company increased 17.65% at Rs 1238.47 crore for Q3FY21 as compared Rs 1052.65 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 24.93% rise in its net profit after taxes, non-controlling interests and share of profit of Associates and Joint Ventures at Rs 292.57 crore for the quarter under review as against net profit of Rs 234.19 crore for the same quarter in the previous year. Total income of the company increased by 8.87% at Rs 1316.86 crore for Q3FY21 as compared Rs 1209.54 crore for the corresponding quarter previous year.
